Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 19/20 | 0.59 |
| ▸ | CRBN | Q96SW2 | 19/20 | 0.59 |
| ▸ | IKZF3 | Q9UKT9 | 2/20 | 0.56 |
| ▸ | TNF | P01375 | 1/20 | 0.56 |
| ▸ | IL1B | P01584 | 1/20 | 0.56 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.56 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25647213 | 0.92 | DDB1 (0.59) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL31076875 | 0.83 | CRBN (0.58) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL25647211 | 0.82 | CRBN (0.67) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL25647212 | 0.82 | DDB1 (0.63) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL25647154 | 0.82 | CRBN (0.54) | DDB1CRBNIKZF3ALDH1A1CHRM2 | |
| SCHEMBL25647210 | 0.81 | CRBN (0.66) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL31033684 | 0.81 | DDB1 (0.61) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL25270736 | 0.80 | CRBN (0.70) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL31076948 | 0.80 | CRBN (0.70) | DDB1CRBNIKZF3TNFIL1B | |
| SCHEMBL25647193 | 0.80 | DDB1 (0.63) | DDB1CRBNIKZF3TNFIL1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446324-A1 | LIGAND COMPOUNDS FOR E3 UBIQUITIN LIGASE, PROTEIN DEGRADERS DEVELOPED ON BASIS OF LIGAND COMPOUNDS, AND USES THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2024-10-16 | — | — | EP | claimed |